Page last updated: 2024-10-24

bupivacaine and Primary Graft Dysfunction

bupivacaine has been researched along with Primary Graft Dysfunction in 1 studies

Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.

Primary Graft Dysfunction: A form of ischemia-reperfusion injury occurring in the early period following transplantation. Significant pathophysiological changes in MITOCHONDRIA are the main cause of the dysfunction. It is most often seen in the transplanted lung, liver, or kidney and can lead to GRAFT REJECTION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sen, I1
Thomas, S1
Arya, VK1
Minz, M1

Trials

1 trial available for bupivacaine and Primary Graft Dysfunction

ArticleYear
Preinduction hemodynamic fluctuations in renal transplant recipients--comparison of two combined anesthesia regimens.
    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2014, Volume: 25, Issue:6

    Topics: Adolescent; Adult; Allografts; Anesthesia, Epidural; Anesthesia, General; Anesthetics, Local; Bupiva

2014